Concentrix (NASDAQ: CNXC) reports quarter and full-year results performance

Rhea-AI Filing Summary

Concentrix Corporation filed a current report to let investors know it has released its financial results for the quarter and year ended November 30, 2025. The company reported these results through a press release dated January 13, 2026, which is included in the filing as Exhibit 99.1.

The company notes that this information is being furnished under the SEC’s Item 2.02 for results of operations and financial condition, meaning it is provided for disclosure purposes and is not treated as formally filed for liability purposes under certain securities laws.

0001803599FALSE00018035992026-01-132026-01-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 13, 2026

CONCENTRIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware			001-39494			27-1605762
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

39899 Balentine Drive, Suite 235, Newark, California						94560
(Address of principal executive offices)						(Zip Code)

(800) 747-0583

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.0001 per share			CNXC			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02.    Results of Operations and Financial Condition.

On January 13, 2026, Concentrix Corporation (the “Company” or “Concentrix”) issued a press release reporting its financial results for the quarter and year ended November 30, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference.

The information contained in this Current Report on Form 8-K is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any Concentrix filing or report with the Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing or report.

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press release issued by Concentrix Corporation on January 13, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 13, 2026			CONCENTRIX CORPORATION
			By:			/s/ Andre Valentine
						Andre Valentine Chief Financial Officer

FAQ

What did Concentrix (CNXC) disclose in this 8-K filing?

Concentrix Corporation disclosed that it has issued a press release reporting its financial results for the quarter and year ended November 30, 2025, furnished as Exhibit 99.1.

Which period do the latest Concentrix (CNXC) results cover?

The reported financial results cover Concentrix’s quarter and full fiscal year ended November 30, 2025.

How did Concentrix provide its quarterly and annual results?

Concentrix provided its results in a press release dated January 13, 2026, which is included with the report as Exhibit 99.1.

Is the Concentrix earnings information considered filed with the SEC?

The company states that the information is being furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

Where can investors find the detailed Concentrix (CNXC) financial figures?

Detailed figures are contained in the press release attached as Exhibit 99.1 to the report.

Who signed the Concentrix 8-K reporting the latest results?

The report was signed on behalf of Concentrix Corporation by Andre Valentine, Chief Financial Officer.